Wish you could get HEOR & RWE projects started faster, cheaper, & using the most optimal vendor? Do you want to connect with new buyers in this age of reduced face-to-face business development? Some of the biggest challenges in HEOR & RWE are long contracting time, lack of RFI […]
Blog Post Mulls Indirect Benefits in Value Assessments
A recent blog post published on Health Affairs highlights some key reasons why indirect benefits should be factored into value assessments. The authors, National Pharmaceutical Council Vice President of Research Michael Ciarametaro et al., suggest indirect benefits in value assessments have "the […]
Predictions for RWE in 2020
A recent article published on PharmaTimes looks at what the future may hold for real-world evidence amid rising interest in the pharmaceutical industry. The author, Verantos CEO Dan Riskin, widespread efforts to establish robust RWE "provides a significant opportunity to refine the standard of […]
Lin: Clinical Practice Guidelines Not Broken
Family physician and Common Sense Family Doctor blogger Kenneth Lin in a recent post published on MedPage Today writes that while "clinical practice guidelines have problems, they're not broken." Lin was referencing the title of a Health Affairs blog post, "Fixing Clinical Practice Guidelines," […]
Vogenberg Talks Digital Health Tools
The latest Relentless Health Value podcast features Institute for Integrated Health Principal Randy Vogenberg, who discusses the selection of digital health tools for formularies. Vogenberg is also the co-leader for the National Employer Initiative on Specialty Pharmacy and cofounder of the […]
ICER Indefinitely Postpones Public Meetings, Expands Assessment Timelines
In response to the COVID-19 pandemic, the Institute for Clinical and Economic Review (ICER) announced it would indefinitely postpone several public meetings and push out the timelines for assessments. The following details were provided in a press release sent out Wednesday morning: Sickle […]
AMCP Cancels Annual Meeting
The Academy of Managed Care Pharmacy (AMCP) has canceled its annual meeting, which was set to begin April 21, saying that holding the meeting amid the COVID-19 outbreak has "become impermissible." "We deeply appreciate your patience as AMCP leaders and staff have monitored and responded to this […]
Pfizer Offers Its Resources in Fight Against Coronavirus
Pfizer is entering the fight against coronavirus after announcing it would offer its resources for wider use, FiercePharma reports. The drugmaker is also calling on other drugmakers to collaborate, according to the report. "Pfizer calls on all members of the innovation ecosystem—from large […]
ICER Posts Reports Outlining Two Planned Reviews
The Institute for Clinical and Economic Review (ICER) on Friday, March 13, posted two new draft scoping documents outlining planned reviews of bladder cancer treatments, as well as digital apps used for opioid use disorder. According to a press release, ICER is planning to review nadofaragene […]
U.S. Looks to Limit Out-of-Pocket Costs for Insulin Under Medicare
The Trump administration announced a new plan to limit the out-of-pocket costs for insulin to $35 month for Medicare patients, Reuters reports. According to the report, the Centers for Disease Control and Prevention is setting up a testing environment for the payment plan. "While Medicare […]
RWE 2020 Postponed Until Later This Year
The Real-World Evidence 2020: Rare Diseases and Innovative Therapies event has been postponed to later this year in response to the ongoing impact of COVID-19. The event was originally scheduled to begin April 1 in London, U.K. Future Science Events Managing Director Lauren Pulling in an email […]
Webinar to Outline Key Takeaways of ICER’s Updated Value Framework
Boston Healthcare Associates is slated to highlight the Institute for Clinical and Economic Review's (ICER) updated value assessment framework in an upcoming webinar. The event is set to begin 11 a.m. EST March 25. Boston Healthcare Associates' Jordan Hinahara, senior manager, and Thomas Goss, […]
AMCP Seeks Session Proposals for Nexus 2020
The Academy of Managed Care Pharmacy (AMCP) has issued a call for education session proposals as it gears up for its Nexus 2020 meeting, which is set to begin Oct. 20 in Las Vegas. The deadline proposals is April 8. According to AMCP, presentations must: Be based on and reference the best […]
Welltok’s Smith Discusses SDOH
Welltok Consumer Journey Director Jodi Smith in a recent write up published on Modern Healthcare Executive says payers and providers can take aim at social determinants of health (SDOH) by combining environmental and lifestyle data points with traditional data. "The more health plans and […]
Cantrell Highlights Updated AMCP Format
Academy of Managed Care Pharmacy (AMCP) CEO Susan Cantrell in a blog post says the AMCP Format 4.1 features new sections that highlight the evidence needs of health care decision-makers regarding unapproved products. The updated format, which was presented during Nexus 2019, factors in current […]
HIMSS Cancels 2020 Meeting Amid Coronavirus Concerns
In response to recent reports on the coronavirus from the World Health Organization and the Centers for Disease Control and Prevention, HIMSS announced the cancellation of its 2020 HIMSS Global Health Conference & Exhibition. HIMSS in a statement says it was "clearly necessary" to cancel the […]
ICER Launches New Suite of Interactive Tools
The Institute for Clinical and Economic Review (ICER) recently announced a new set of interactive tools that could serve as a significant revenue stream for the organization, Managed Healthcare Executive reports. According to the report, ICER Founder and President Steven Pearson during a recent […]
Course Correction in Precision Medicine ‘Urgently Needed,’ Cooper, Paneth Say
"A course correction is urgently needed," Loyola University Medical School's Dr. Richard Cooper and Michigan State University's Nigel Paneth write, referring to precision medicine, in a recent opinion piece published on STAT. Cooper and Paneth write that a "civil war" has begun in the biomedicine […]
Oscar Health’s $3 Drug List Looks to Boost Adherence, Lower Pricing
In an effort to bolster patients' medication adherence while also reducing drug spending, Oscar Health developed the $3 Drug List. According to a HealthPayerIntelligence report, the list includes 100 drugs that a team of researchers identified as "maintenance medications" — drugs that patients […]
Advance Registration Deadline for AMCP 2020 Nears
The deadline for advance registration for the Academy of Managed Care Pharmacy's (AMCP) annual meeting in Houston is midnight PST March 13. Participants who sign up for advance pricing will save $100 in registration fees. AMCP 2020 is set to kick off April 21 in Houston, Texas. "Join 4,000+ […]
Using RWD for Rare Diseases
OM1's Kathryn Starzyk, senior director of real-world evidence, in a recent tHEORetically Speaking blog post outlines how real-world data tools can be used to tackle key hurdles in the rare disease landscape. RWD, for example, could help streamline diagnoses, she writes. "The ability to use the […]
Report: FDA Program Leads to Billions in Price Increases
A program launched in 2006 by the Food and Drug Administration (FDA) helped ensure the safety and effectiveness of older drugs, but there were unintended results, according to a STAT report. The Unapproved Drugs Initiative, according to the report, ultimately led to billions in drug price hikes […]
Parents Shocked by Price of Children’s Hormone Drug
The parents of an 8-year-old girl were shocked when they discovered the price for a children's hormone blocker cost about eight times more than the adult version, according to an NPR report. The Taksali's tell NPR their insurer wouldn't cover the cheaper version of the drug, Vantas, and their […]
HIMSS, ISPOR Partner to Bolster Membership Value
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Healthcare Information Management Systems Society (HIMSS) have partnered in a bid to bolster value for each society's members. ISPOR and HIMSS, according to the announcement, are looking to collaborate on "benefits, […]
AHIP: MCO’s Generated $6.5 Billion in Medicaid Savings in 2018
A new report by America's Health Insurance Plans (AHIP) suggests managed care organizations were able to save Medicaid programs roughly $6.5 billion on prescription drugs in 2018. According to a HealthPayerIntelligence report, AHIP partnered with The Menges Group to check the savings of managed […]
ICER Announces RWE Partnership with Aetion
The Institute for Clinical and Economic Review (ICER) is partnering with Aetion to "generate decision-grade real-world evidence," the drug pricing watchdog announced Monday. According to a press release, Aetion's solutions would help ICER discover where it can use RWE to bolster its […]
Article Highlights Digital Healthcare Ecosystem
HEOR researcher and scientific writer Michele Cleary in the latest Value & Outcomes Spotlight featured article offers expert perspectives on the evolving digital healthcare landscape. The article includes input from Edwards Lifesciences' Katie Szyman, Microsoft and Foundation29's Julian Isla […]
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic Platform, hēRo3
Policy Analysis Inc. (PAI), a Boston-based health-economics consultancy, on Wednesday, Feb. 19, announced that it had signed a multi-year deal with the Institute for Clinical and Economic Review (ICER) that will allow the drug-pricing watchdog to expand its use of PAI's new cloud-based economic […]
COTA White Paper Spotlights Perspectives on RWE
A new white paper from COTA offers unique perspectives on real-world evidence (RWE), including input from Pfizer and Bristol-Myers Squibb executives. COTA says that while RWE shows some promise, there are a number barriers preventing widespread adoption. "In 2020, we expect many of these […]
Report Outlines How States Can Act on Drug Spending
A recent report by the Center for American Progress outlines how states can take action to reduce prescription drug spending. According to the report, states looking to reduce spending face a number of major challenges. "Federal law preempts the most sweeping, comprehensive state reforms that […]
